Curriculum vitae

First Name: Amir Last Name: Bahrami Date of Birth: January 26, 1954 Place of Birth: East Azarbyjan Sex: Male Marital status: Married Religion: Islam Office Address: Imam Reza Medical center, Division of Endocrinology and Metabolism. University of Medical Sciences, P. O. Box: 51335 – 1896 Tabriz, Office phone: + 98. 0411 – 3357850 + 98. 0411 – 5419899 Office Fax: + 98. 0411 – 3357850 E – mail: [email protected] OR [email protected]

PRESENT POSITION Professor of Medicine and Endocrinology, Tabriz University of Medical Sciences Director, Division of Endocrinology and Metabolism Tabriz University of Medical Sciences Director, Training Program in Endocrinology and Metabolism Tabriz University of Medical Sciences Chief, Endocrine and Metabolism service Attending staff, Tabriz University of Medical Sciences, Imam Reza Medical center EDUCATION: Medical Sciences, University of Tabriz, faculty of Medicine 1973 – 1979 Internship University of Tabriz, Imam Khomeini Hospital 1979 – 1980 M. D., University of Tabriz, Imam Khomeini Hospital 1980 – 1981 Iranian Medical council License 1981 Resident in Internal Medicine, University of Tabriz, Department of Internal Medicine, University Teaching Hospitals University of Tabriz 1983 – 1985 Resident in Internal Medicine, Department of Internal Medicine, University Teaching Hospitals, University of 1986 – 1987 Having passed the National Board Examinations in Internal Medicine 1987. National Board certification in Internal Medicine 1987 Fellow in Endocrinology and Metabolism, common program in fellow Training in Endocrinology and Metabolism, Tehran, Iran, and shahid Beheshti Universities of Medical sciences 1989 – 1992 Having passed National Board Examinations in the subspecialty of Endocrinology and Metabolism 1994 National Board certification in the subspecialty of Endocrinology and Metabolism 1994

1 Having passed the workshop on research Methodology held by Ministry of Health, Education and Treatment, Research Council, Ramsar 1988 Having passed the workshop on teaching skills held by Tabriz University of Medicine Sciences, Tabriz 1995 Having passed the workshop on advanced techniques of Research Methodology held by Endocrine and Metabolism Research center, Shahid Beheshti University of Medical Sciences 1995 Having passed the Medical writing workshop held by Tabriz University of Medical Sciences 1994

ACADEMIC EXPERIENCE: Assistant Professor of Medicine, Tabriz University of Medical sciences, Tabriz 1987 – 1998 Attending Staff, Teaching Hospitals, Tabriz University of Medical Sciences 1987 – present Associate Professor of Medicine and Endocrinology, Tabriz University of Medical Sciences 1999 – 2007 Professor of Medicine and Endocrinology, Tabriz University of Medical Sciences 2008 –present

Visiting scientist, University of Toronto, Department of Medicine, Division of Endocrinology and Metabolism, and thyroid research center, 1992 – 1993 Instructor in Medicine and Endocrinology Tabriz University of Medical Sciences 1993 – present ADMINSTRATIVE EXPERIENCE Associate chief, Department of Medicine, Tabriz University of Medical Sciences 1987 – 1989 Chief Department of Medicine, Tabriz University of Medical Sciences 1993 – 1994 Chief Division of Endocrinology and Metabolism 1994 – present Program director, Division of Endocrinology and Metabolism, Tabriz University of Medical Sciences 1994 – present Chief, Endocrine clinics, Tabriz University of Medical Sciences 1994 – 2001 VISITING OPPORTUNITIES Visiting Scientist; Department of Medicine, Division of Endocrinology and Metabolism, Sunnybrook Health Sciences center, Welselly Hospital, Thyroid research center, University of Toronto, Toronto. Canada. 1992 – 1993 MEMBERSHIPS: Member of Iranian society of Internal Medicine 1989 – present Member of Iranian society of Endocrinology and Metabolism 1992 – present Member of the Endocrine society 1997 – present Member of Iranian Medical council 1981 – present Manager of Iranian society of Internal Medicine, Tabriz Branch 1999 – present Member of Scientific Manager of Iranian Diabetes Association, Tabriz Branch 1998 – present Member of Iranian Board of Internal Medicine 1998 – 2001 Member of National Board Examinations for Fellow Selections in Endocrinology and Metabolism 2002 – present

2 Member of Iranian Board of Endocrinology and Metabolism 2002 – present Executive Manager of Iranian Medical council, Tabriz Branch 2001 – 2004 Member of Research council of Tabriz University of Medical Sciences 1994 – 1996 Member of teaching council of Tabriz University of Medical Sciences 1993 – 1994

Member of committee in the subspecialty of internal medicine, National Research Center for Medical Sciences, I.R Iran 2004 - continued EDITORIAL POSITIONS: Editorial Board, Iranian Journal of Endocrinology and Metabolism 1998 – present Editorial Board, Iranian Journal of Diabetes and Lipids 2002 – present Editorial Board, International Journal of Endocrinology and Metabolism 2003 – present Editorial Board, Medical Journal of Tabriz University of Medical Sciences 2005 – present SCIENTIFIC REVIEWER FOR: Medical Journal of Tabriz University of Medical Sciences 1994 – present Medical Journal of Ardabil University of Medical Sciences 2002 – present Medical Journal of Tehran University of Medical Sciences 2000 – present Iranian Journal of Medical Sciences 1994 – present Iranian Journal of Endocrinology and Metabolism 1998 – present Iranian Journal of Diabetes and Lipids 2002 – present International Journal of Endocrinology and Metabolism 2003 – present Journal of Research in Medicine, Shaheed Beheshti University of Medical Sciences, 1995 – present The Journal of University of Medical Sciences 1999 – present HONORS: Number one Award of Tabriz University of Medicine Sciences for Earning the first Rank in the National Board Certification Examination in Internal Medicine in 1987 Number one Award of Medical Graduates of Tabriz University of Medicine Sciences for being nominated as “distinguished teacher” in 1988, 1994, 1997 Number one Award of Medical students of Tabriz University of Medicine Sciences for being nominated as “distinguished teacher in pathophysiology course” in 1989, 1994, 1998 Number one Award of Medical students of Tabriz University of Medicine Sciences for being nominated as “distinguished bedside teacher” in 1996, 2001 Award of Tabriz University of Medicine Sciences for being nominated as “distinguished physician” in 1995 Award of Tabriz University of Medicine Sciences for being nominated as “distinguished teacher” in bedside Medicine 1999 Number one Award of Residents of Internal Medicine for being nominated as “distinguished teacher” 2001

3 Number one Award of Medical council of Medical services organization, East Azarbaijan Branch, for being nominated as “one of the Best Doctors in Tabriz” in 2004 Award of Medical council of Islamic Republic of Iran, Tabriz organization for being nominated as “distinguished physician” in 2004 PUBLICATIONS: BOOKS: 1) Translation of “Endocrine pathophysiology” to Farsi 1994 2) Translation of “Thyroid Diseases, the facts” to Farsi 1995

3) Translation of “Physician’s Guide to Diagnosis, prevention and Treatment of osteoporosis” to Farsi 2002 4) Translation of “Degowin’s Diagnostic Examination” to Farsi 2002 5) Editor of “Adrenal Disease; pathophysiology, Diagnosis, and Treatment 2004” 2001

6) Editor, sections on adrenal cortex and Endocrine hypertension. In Endocrine disorders, first edition by F. Azizi, B. Larijani, F. Hosseinpanah. 2007 Publisher Iranian Endocrine society ARETICLES: 1) Bahrami A., Kahnamoei, S.: Spontaneous retroperitoneal rupture of extra-adrenal pheochromocytoma mimicking leaking aortic aneurysm: a case report and review of the literature. Med. J. IRI. 1990; 4: 313 2) Bahrami A., Azizi, F.: Genital tuberculosis as a cause of female infertility. Journal of the faculty of medicine, Shaheed Beheshti University of Medical Sciences 1991; 15: 59 3) Hidarnejad, H., Bahrami A.: Lower lung field tuberculosis: an analysis of 146 cases. Med. J. IRI. 1991; 5: 111 4) Azizi, F., Sarshar, A., Nafarabadi, M., Ghazi, A., Kimiager, M., Noohi, S., Bahrami A., Kalantari, S.: Impairment of neuromotor and cognitive development in iodine-deficient schoolchildren with normal physical growth. Acta Endocrinol 1993; 129: 501 5) Khodaiani, E., Bahrami A., Kolahi, S., Hosseini, F: Skin lesions in diabetic patients: study of 454 patients. Medical J. of Tabriz University of Medicine Sciences 1998; 32: 30 6) Babaei S.H., Razi A., Bahrami A., et al: A survey of skin, hair or nail signs in patients with hypo – and hyperthyroidism. Medical Journal of Tabriz University of Medicine Sciences 2001; 35 (50): 9 - 14 7) Shakori, S.K., Sadigh Mostofi, Bahrami A., Rahbar, M: Carpal tunnel syndrome inpatients with acromegaly.Medical J. of Tabriz University of Medicine Sciences 2003; 37(59): 55 8) Bahrami A., Abedmoghaddam, AR: The long term results of bilateral adrenalectomy for Cushing's disease, Iranian J. Endocrinol . Metab. 2004; 6 (3): 255 - 263 9) Bahrami A.,Islamian, F: Thyrotoxic periodic paralysis in Azeri Iranians. International J. Endocrinol. Metab. 2004; 2: 35 10) Rahbani Nobar, M., Bahrami A: Correlation between. Serum levels of cholesterol and Homocysteine with oxidative stress in hypothyroid patients. Internat. J. Endocrinol. Metab. 2004; vol. 2 (No 2) 103 - 109

4 11) Bahrami A: High prevalence of IGT and DM in women with polycystic ovary syndrome, screening of all women is necessary. Iranian. J. of Diabetes and Lipid disorders summer 2004; vol. 3(No 1) 141 - 148

12) Zarghami N, Bahrami A, Mobasseri M, Larijani B, Karimi P, Alani B. Study of correlation between IGF-I and leptin in type II diabetic patients and control. ISOH. 2005 13) Bahrami A.,Montazeri V, Barband AR, Poorzand A, Mobaseri M. Advanced bone disease as the most common clinical presentation of primary hyperparathyroidism in Iranians: Clinical and laboratory features of 62 patients from North-Western Iran. Int J Endocrinol Metab 2006; 4: 19-29

14) Zarghami N, Bahrami A, Mobasseri M, Larijani B, Karimi P, Alani B. Evaluation of Correlation Between IGF-I and Leptin in Type II Diabetic Patients and Healthy Controls. Iranian Journal of Diabetes and Lipid Disorders; 2006 Vol. 5 (No 3), 187 – 196

15) Bahrami A. Methimazole-Induced Agranulocytosis in a Mother and her Young Daughter, the Possible Role of Genetic Factors in the Development of Methimazole-Induced Agranulocytosis. Int J Endocrinol Metab 2006; 4: 112 - 115

16) Jalilzadeh SH, Bahrami A, Eftekharosadat B, Mobasseri M, Pezeshki Z. Peripheral Nerve Function in Subclinical Hypothyroidism: A Case-Control Study. Int J Endocrinol Metab 2006; 4: 78 - 83

17) Larijani B, Moayyeri A, Keshtkar AA, Hossein-Nezhad A, Soltani A, Bahrami A, Omrani GH, Rajabian R, Nabipour I. Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis Study. J Clin Densitom. 2006 Jul-Sep; 9 (3): 367 – 74

18) Moayyeri A, Soltani A, Bahrami A, Sadatsafavi M, Jalili M, Larijani B. Preferred skeletal site for osteoporosis screening in high-risk populations. Public Health. 2006 Sep; 120 (9): 863 – 71. Epub 2006 M25.

19) Bahrami A. Thionamide Associated Agranulocytosis: Low Incidence with Low Doses of Methimazole. Int J Endocrinol Metab 2006; 4: 210 – 215

20) Bahrami A, Zarghami N, Khajehali L. Association between C-Reactive Protein and HbA1c among patients with type 2 diabetes mellitus Iranian Journal of diabetes and lipid disorders 2007 6(3): 263 – 269

21) Mohammadzadeh GH, Zarghami N, Bahrami A. Comparision of serum Adiponectin levels in diabetic and non-diabetic obese subjects. 11th APFCB. China Medical Journal. Beijin. Oct 2007; China

22) Bahrami A., et al. Results of long term follow up of women with postpartum thyroiditis. (under review)

23) Bahrami A., Lipoprotein alterations in women with polycystic ovary syndrome. (under review)

24) Bahrami A., Judeiri L., Results of long term follow up of patients with solitary thyroid nodule having benign FNA cytology. (under review)

25) Bahrami A., Nikniaz AR., et al. The prevalence of vitamin – D deficiency in an urban adult population in Tabriz city (under review)

5 26) 1A. Barband, 2Y. Ahmadi, 3A. Bahrami and 1F. Kakaii. Laparoscopic Transabdominal Adrenalectomy for pheochromocytoma Comparison with Conventional Open Adrenalectomy. Research Journal of Medical Sciences 2008; 2(2): 77 – 81

27) 1Bahrami A, 2Kamali K, 1Ali-Asgharzadeh A, 3Hosseini P, 2,3Heshmat R, 4Khorram Khorshid HR, 5Gharibdoust F, 6Madani SH, 3Larijani B. Clinical application of oral form of ANCIPARSTM and in combination with topical form as a new treatment for diabetic foot ulcers: A randomized clinical trial. DARU 2008; 16: suppl.

28) 1Larijani B, 1,2Heshmat R, 3Bahrami A, 4Delshad H, 5Ranjbar Omrani G, 2Mohammad K, 1Heidarpour R, 1Mohajeri Tehrani MR, 2Kamali K, 6Farhadi M, 7Gharibdoust F, 8Madani SH. Effects of intravenous Semelil (ANGIPARSTM) on diabetic foot ulcers healing: A multicenter clinical trial. DARU 2008; 16: suppl

29) Bahrami A. Primary Hyperparathyroidism in Iran: A Review International Journal Endocrinology Metabolism. 2008 March 1: 50 - 57

30) Barband A, Ahmadi Y, Bahrami A, Kakaii F Laparoscopic Transabdominal Adrenalectomy for pheochromocytoma Comparison with Conventional Open Adrenalectomy Research Journal of Biological Sciences 2008

31) Aliasgharzadeh A, Aghamohammadzadeh N, Mobasseri M, Niafar M, Najafipour F, Bahrami A, Derogar R, Mashrabi O Study of contraception status of female diabetic patients in childbearing years. Research Journal of Biological Sciences 2008

32) Moradzadeh K, Larijani B, Keshtkar AA, Hossin-Nezhad A, Rajabian R, Nabipour I, AOmrani GH, Bahrami A, Gooya M.M, Delavari A Normative Values of Vitamin D Among Iranian Population: A Population Based Study International Journal of Osteoporosis and Metabolic Disorders. 2008; Vol:1(1):8-15

33) Aliasgharzadeh A, Bahrami A, Najafipour F, Astanei A, Niafar M, Aghamohammadzadeh N, Mobasseri M, Relation Between Secretory Status of Growth Hormone, Serum Concentration of Insulin-like Growth Factor I, and Insulin-like Growth Factor Binding protein 3 with Bone mineral density in Postmenopausal Women International Journal Endocrinology Metabolism 2008

34) Farzad Najafipour, Akbar Aliasgarzadeh, Naser Aghamohamadzadeh, Amir Bahrami, Majid Mobasri, Mitra Niafar, Manouchehr Khoshbaten A cross-sectional study of metabolic andendocrine complications in beta-thalassemia major Annals of Saudi Medicine Sep-Oct 2008; Vol 28(5) :361-366

35) Mohammadzadeh GH, Zarghami N, Bahrami A, Larijani B, Serum levels of adiponectin in Obese Diabetic and nondiabetic populations Iranian journal of Diabetes and lipid disorders. 2007; Vol: 7(2): 177-187.

36) Zarghami N, Bahrami A, Mobasseri M, Larijani B, Karimi P, Alani B. evaluation of serum concentrations of IGF-1 and leptin in patients with type 2DM and healthy control subjects. Iranian Journal of Diabetes and lipid disorders 2006; Vol: 5(3), 187-196.

37) Bahrami A, Zarghami N, Khajehali L, Association between C-Reactive protein and HbA1C among patients with type 2DM. Iranian Journal of Diabetes and lipid disorders 2007; Vol: 6(3), 263- 269.

6 38) E Mir 1, A Hossein-nezhad 1, A Bahrami 2, MR Bekheirnia 1, E Javadi 1, A Afshar Naderi 3, *B Larijani 1. Adequate Serum Copper Concentration Could Improve Bone Density, Postpone Bone Loss and Protect Osteoporosis in Women. Iranian J Publ Health, 2007, A supplementary issue Osteoporosis, pp.24-29

39) E Mir 1, A Hossein-nezhad 1, A Bahrami 2, MR Bekheirnia 1, E Javadi 1, A Afshar Naderi 3, *B Larijani 1. Serum Zinc Concentration Could Predict Bone Mineral Density and Protect Osteoporosis in Healthy Men. Iranian J Publ Health, 2007, A supplementary issue on Osteoporosis, pp.30-36

40) Sharifi N, Khoshbaten M, Aliasgharzadeh A, Bahrami A. Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran. Int J Diab Dev Ctries. July-September 2008; Vol 28(3), 95-99

41) R Heshmat 1,2, K Mohammad 2, SR Majdzadeh 2, MH Forouzanfar 1,2, A Bahrami 3, GH Ranjbar Omrani 4, I Nabipour 5, R Rajabian 6, A Hossein-Nezhad 1, M Rezaei Hemami 1,2, AA Keshtkar 7, M Pajouhi 1, *B Larijani 1. Vitamin D Deficiency in Iran: A Multi-center Study among Different Urban Areas. Iranian J Publ Health, 2008, A supplementary issue on Osteoporosis and Bone Turnover, No.1, pp.72-78

42) HR Aghaei Meybodi 1, R Heshmat 1, Z Maasoumi 1, A Soltani1, A Hossein-nezhad 1, AA Keshtkar 2, A Bahrami3, R Rajabian 4, I Nabipour 5, GH Omrani 6, M Pajouhi1, *B Larijani 1. Iranian Osteoporosis Research Network: Background, Mission and Its Role in Osteoporosis Management. Iranian J Publ Health, 2008, A supplementary issue on Osteoporosis and Bone Turnover, No.1, pp.1-6

43) Aliasgharzadeh A, Bahrami A, Ramazani M, Najafipur F, Moradi A, Larijani B. Incidence of osteoporotic hip fracture in above 50 year old peoples of Tabriz in years 2004-2006. Iranian Journal of Endocrinology and Metabolism March 2009; Vol: 10, No: 6, Page: 656

44) Mobasseri M, Aliasgharzadeh A, Ebrahimzadeh Z, Najafipoor F, Niafar M, Aghamohammadzadeh N, Bahrami A. Hyperhomocysteinemia and bone mineral density: a case-control study. Pak J Med Sci. 2009; Vol, 25 No, 1 Page 91-96

45) Niafar M, Bahrami A, Aliasgharzadeh A, Najafipour F, Mobasseri M. Vitamin D status in healthy postmenopausal Iranian women. JRMS. May and June 2009; Vol 14, No 3, Page 1-7

46) Majid Mobasseri, Akbar Aliasgharzadeh, Zinolabedin Ebrahimzadeh, Farzad Najafipoor, Mitra Niafar, Naser Aghamohammadzadeh, Amir Bahrami. HYPERHOMOCYSTEINEMIA AND BONE MINERAL DENSITY: A CASE - CONTROL STUDY. Pak J Med Sci 2009 Vol. 25 No. 1

47) Nasrin Sharifi, Manouchehr Khoshbaten, Akbar Aliasgarzadeh, Amir Bahrami. Celiac disease in patients with type 1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran. Int J Diab Dev Ctries July-September 2008 Volume 28 Issue 3

48) Niafar M, Najafipoor F, Bahrami A, Subclinical Thyroid Disorders In Postmenopausal Women of Iran. Journal of Clinical and Diagnostic Research, 2009 Dec; (3): 1853 - 1858

49) Mitra Niafar, Amir Bahrami, Akbar Aliasgarzadeh, Naser Aghamohammadzadeh, Farzad Najafipoor, Majid Mobasseri. Vitamin D status in healthy postmenopausal Iranian women. JRMS/May and June 2009; Vol 14, No 3

7 50) Mobasseri M1, Bahrami A1. Zargami N2 Aliasgharzadeh A1, Rhmati M2, Delazar A3, Najafipoor F1, Niafar M1, Aghamohammadzadeh N1. Effect of Total Extract of Urtica Dioica on Insulin and C- Peptide Secretion From Rat (RIN5F) Pancreatic  Cells and Glucose Utilization by Human Muscle Cells. Iranian Journal of Endocrinology and Metabolism March 2010; Vol: 11, No: 6, Page: 743

51) Bahrami A1, Aliasgharzadeh A1, Sarabchian M1, Mobasseri M1, Heshmat R2, Gojazadeh M3. Efficacy of Oral ANGIPARS in Chronic Diabetes Foot Ulcer: A Double Blind Placebo Controlled Study. Iranian Journal of Endocrinology and Metabolism March 2010; Vol: 11, No: 6, Page: 732

52) Nasser Aghamohammadzadeh1, Akbar Aliasgarzadeh2, Leila Baglar3, Seddigheh Abdollahifard4, Amir Bahrami5, Farzad Najafipour6, Mitra Niafar7. Comparison of Metformin and Cyproterone- Estrodiol Compound Effect on HS C-Reactive Prottttein and Serum Androgen Levels in Patients with Polycystic Ovary Syndrome. Pak J Med Sci 2010 Vol 26 No 2 P: 347

53) Reza Esteghamati', Reza Rajabian2, Masoud Amini3, Amir Bahrami4, Mohammad Ebrahim Khamseh5, Mohammad Afkhami-Ardekani6, Ehsan Parvaresh Rizj7. The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study - the Iran subgroup of the IMPROVE™ study. Endokrynologia Polska/Polish Journal of Endocrinology 2010; 61 (4), pag: 346

54) Zahra Abbasi Ranjbar1*, Amir Bahrami1, Farzad Najafipoor1, Majid Mobassery1. Transient diabetes insipidus in a woman with a twin pregnancy: A case report. Int J Endocrinol Metab. 2010;8(2): 94 - 96

CONGRESSES NATIONAL 1) Bahrami A: Articular involvement in human Brucellosis. The first congress of Iranian society of internal Medicine April 1989 Tehran Iran 2) Bahrami A: Hypercalcemia of primary hyperparathyroidism Masked by co-existing hypothyroidism. The second congress of Iranian society of Internal Medicine. April 1995 Shiraz Iran 3) Bahrami A: Spontaneous disappearance of solid thyroid nodules following fine needle Aspiration. The 6th congress of Iranian society of Internal Medicine June 1995 Tabriz Iran 4) Bahrami A: et al. Role of FNA in the diagnosis and management of thyroid nodules, report of results in 1000 cases. The 8th congress of Iranian society of Internal Medicine. April 1998 Guillan, Rasht 5) Bahrami A: Serum Lipid changes in 620 patients with type 2 DM. The 8th congress of Iranian society of Internal Medicine. April 1998 Guillan, Rasht 6) Bahrami A., Aghamohammadzadeh N: The study of Metabolic effects of Metformin in type 2 diabetic patients with secondary sulfonylurea failure. The 8th congress of Iranian society of Internal Medicine. May 12 – 15 1998 Guillan, Rasht 7) Bahrami A: et al. The effects of smoking on serum thyroid hormone concentrations, thyroglobulin, Goiter size and ophthalmopathy in patients with Graves’ disease The 9th congress of Iranian society of Internal Medicine May 1999 Tehran Iran 8) Bahrami A: Renal stone disease in Iranian hyperparathyroid patients. The sixth congress of Iranian urological Association June18 – 21 2003 Tehran Iran 9) Bahrami A., Ashtiani, L: Long term results of follow up of women with postpartum thyroiditis. The 14th congress of Iranian society of Internal Medicine 19 – 22 May 2003 Tehran Iran

8 10) Bahrami A., Abedimoghaddam, AR: Long term results of bilateral adrenalectomy for Cushing's disease. The 14th congress of Iranian society of Internal Medicine 19 – 22 May 2003 Tehran Iran 11) Bahrami A., Ghazizadeh, F: Long term results of antithyroid therapy of Graves’ hyperthyroidism after iodinzation of salt in the country, possible role of iodine supplementation in an increase in relapse rate the 15th congress of Iranian society of Internal Medicine 1 – 4 May 2004 Tehran Iran 12) Bahrami A., Ainetchi, S: Etiology, clinical features, laboratory finding, and diagnostic problem in hypoparathyroid patients. The 15th congress of Iranian society of Internal Medicine 1 – 4 May 2004 Tehran Iran 13) Bahrami A., et al. The study of the level of awareness of diabetic patients from their disease The 4th National congress of Nutrition. October 1996 Tehran Iran 14) Bahrami A., The spectrum of endocrine tumors. The experiences of endocrine clinics of Tabriz University of Medicine Sciences. The 11th annual congress of Institute of cancer, Endocrine tumors. March 1999 Tehran Iran 15) Ghaemmaghami H., Abolfathi AK., Bahrami A: The role of serum fructosamine in determining glycemic control in diabetic patients. The third National congress of biochemistry and laboratory Medicine. September 1995 Tabriz Iran 16) Bahrami A: Gynecomastia and acanthosis nigricans in a patient with CAH. The 6th Iranian congress of Internal medicine. 1995 Tabriz Iran 17) Bahrami A: Anabolic therapy of osteoporosis. Abstract book of osteoporosis seminar. 2001 Tehran Feb. 1st Pp 63 - 67

CONGRESSES INTERNATIONAL 1) Azizi F., Kimiagar M., Nafarabadi MT., Bahrami A: Normalization of serum thyroglobulin and thyroid function test two years following iodized oil injection. The second international congress on Endocrine disorders. May 12 – 14 1992 Tehran Iran 2) Bahrami A: Is low doses of methimazole safer than high doses with regard to agranulocytosis? The 4th international congress on Endocrine disorders. Nov. 20 – 22 1996 Tehran Iran 3) Rajaee M., Bahrami A. et al. The study of phagocytosis in type 1 diabetic patients. The 4th International congress of Allergy and Immunology. May 1999 Iran

4) Bahrami A: Thyrotoxic periodic paralysis (TPP) in Iranians. The 10th Asia – Oceania congress of Endocrinology. Oct. 30th – Nov. 3rd 1994 Beijing China 5) Bahrami A: advanced bone disease as the most common clinical presentation of primary hyperparathyroidism in Iranians. The 5th International congress of Endocrine Disorders 6 – 9 Sep. 1999 Tehran Iran 6) Bahrami A., Islamian F., Thyrotoxic periodic paralysis in Iran: A decade of experiences on clinical features, laboratory findings, predisposing factors, diagnosis, and treatment of 53 cases. The 6th International congress of Endocrine Disorders. Oct 5 – 9 2001 Tehran Iran 7) Bahrami A., Montazeri V., Ismaeili HA., Eshraghi Y. et al. FNA of thyroid nodules; comparison of FNA cytology result with post-thyroidectomy nodule histology in 432 patients. The 6th International congress of Endocrine Disorders. Oct 5 – 9 2001 Tehran Iran 8) Bahrami A., The effect of smoking on duration of remission of hyperthyroidism of Graves’ disease after long term treatment with thionamides. The 13th congress of Iranian society of Internal Medicine. 29 April – 2 May 2002 Tehran Iran 9 9) Dabiri S., Bahrami A., Aliaskarzadeh A., et al: Evaluation of metastatic differentiated thyroid carcinoma with Tc 99m – MIBI . The 7th International congress of Endocrine disorders. Oct. 8 – 11 2004 Tehran Iran 10) Rahbani M., Bahrami A., et al: Correlation between serum levels of cholesterol and homocysteine with oxidative stress in hypothyroid patients. The 7th International congress of Endocrine disorders. Oct. 8 – 11 2004 Tehran Iran 11) Bahrami A., Nikniaz AR., et al: Prevalence of vitamin D deficiency in an urban adult population, in Tabriz city. The first International Seminar on Prevention Diagnosis and Treatment of Osteoporosis. Sept. 23 – 24 2004 Tehran Iran 12) Bahrami A., Nikniaz AR., et al: Bone Mineral Density (BMD) of the spines and hip in an urban adult population: Population based study in Tabriz city. The 7th International congress of Endocrine disorders. Oct. 8 – 11 2004 Tehran Iran 13) Bahrami A., Nikniaz AR., et al: The relationship between BMI and prevalence rate of osteopenia and osteoporosis in an urban adult population. The 7th International congress of Endocrine disorders. Oct. 8 – 11 2004 Tehran Iran 14) ) Bahrami A: High Prevalence of impaired glucose tolerance and type 2 DM in patients with PCOS. The 7th International congress of Endocrine disorders. Oct. 8 – 11 2004 Tehran Iran

15) Mir E, Hossein-nezhad A, Bahrami A, Bekheirnia MR, Shafahi AR, Larijani B. Adequate serum copper concentration could improve peak bone mass and postpone bone loss in women. IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2.

16) Mir E, Bahrami A, Hossein-nezhad A, Bekheirnia MR, Shafahi AR, Larijani B. Plasma zinc concentration could predict bone mineral density and protect osteoporosis in men. IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2.

17) Moayyeri A, Larijani B, Keshtkar AA, Hossein-nezhad A, Bahrami A, Omrani GH, Rajabian R, Nabipour I, Soltani A. Peak bone mass of Iranian Population: the Iranian multicenter osteoporosis study (IMOS). IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2.

18) Moradzadeh K, Larijani B, Keshtkar AA, Hossein-Nezhad A, Rajabian R, Nabipour I, Omrani GH, Bahrami A, Gooya MM, Delavari AR. Normative values of vitamin D and prevalence of vitamin D deficiency among Iranian Population. IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2.

19) Moayyeri A, Larijani B, Keshtkar AA, Hossein-Nezhad A, Bahrami A, Omrani GH, Rajabian R, Nabipour I, Soltani A. Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis Study. IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2. P192MO

20) Moayyeri A, Soltani A, Bahrami A, Tavakoli Shalmani H, Ahmadi Abhari S, Larijani B. Preferred skeletal site for osteoporosis screening in high-risk populations. IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2. P240MO

10 21) Moradzadeh K, Larijani B, Keshtkar AA, Hossein-Nezhad A, Rajabian R, Nabipour I, Omrani GH, Bahrami A, Gooya MM, Delavari AR. Normative values of vitamin D and prevalence of vitamin D deficiency among Iranian population. IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2. P147MO

22) Mir E, Bahrami A, Hossein-Nezhad A, Bekheirnia MR, Shafahi AR, Larijani B. Zinc plasma concentration could predict bone mineral density and protect osteoporosis in men. IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2. P527SU

23) Mir E, Hossein-Nezhad A, Bahrami A, Bekheirnia MR, Shafahi AR, Larijani B. Adequate serum copper concentration could improve peak bone mass and postpone bone loss in women. IOF World Congress on Osteoporosis. June 2 – 6, 2006 Toronto, Canada. Osteoporosis International, Volume 17 (2006) Supplement 2. P557SU

24) Niafar M, Aliasgharzadeh A, Bahrami A, Najafipur F. Prevalence of thyroid dysfunction in the elderly women of Iran. The 11th European Congress of Endocrinology. 25-29 April 2009, Istanbul, Turkey. Endocrine Abstracts, Volume 20 (April 2009) P137

25) Mobasseri M, Aliasgharzadeh A, Bahrami A, Niafar M, Aliasgharzadeh A, Bahrami A, Zargami N. The effects of Urtica diocia on rat pancreatic  cell. The 11th European Congress of Endocrinology. 25-29 April 2009, Istanbul, Turkey. Endocrine Abstracts, Volume 20 (April 2009) P423

26) Mobasseri M, Aliasgharzadeh A, Aghamohammadzadeh N, Zargami N, Bahrami A. Urtica diocia effects on glucose utilization by human muscle cells. The 11th European Congress of Endocrinology. 25- 29 April 2009, Istanbul, Turkey. Endocrine Abstracts, Volume 20 (April 2009) P424

27) Aliasgharzadeh A, Bahrami A, Ramazani M, Najafipur F, Moradi A. The incidence of osteoporotic hip fracture in north west of Iran. The 11th European Congress of Endocrinology. 25-29 April 2009, Istanbul, Turkey. Endocrine Abstracts, Volume 20 (April 2009) P251

28) Najafipur F, Bahrami A. When antithyroid drugs must be started in patients with hyperemesis gravidarum? The 11th European Congress of Endocrinology. 25-29 April 2009, Istanbul, Turkey. Endocrine Abstracts, Volume 20 (April 2009) P96

29) Najafipur F, Bahrami A. Evaluation of metabolic and endocrine complications in -Thalassemia major: cross sectional study of 65 patients. The 11th European Congress of Endocrinology. 25-29 April 2009, Istanbul, Turkey. Endocrine Abstracts, Volume 20 (April 2009) P95

30) Esteghamati AR, Rajabian R, Amini M, Bahrami A, Khamseh ME, Afkhami Ardekani M, Parvaresh Rizi E. Improved Safety and efficacy Profile in Patients with Type 2 Diabetes Treated with Biphasic Insulin Aspart 30 (BIAsp 30): Iran Subgroup of the IMPROVE Study. . The 11th scientific sessions. June 5-9, 2009, Morial Convention Center New Orleans, LA. Diabetes (Abstract Book), Volume 58 (June 2009) Supplement 1, Page A527

31) Esteghamati AR, Rajabian R, Amini M, Bahrami A, Khamseh ME, Afkhami Ardekani M, Parvaresh Rizi E. Biphasic Insulin Aspart 30 (BIAsp 30) Improves Glycemic Control in Patients with Type 2 Diabetes Regardless of previous Treatment Regimens: The IMPROVE Study in Iran. The 11th scientific sessions. June 5-9, 2009, Morial Convention Center New Orleans, LA. Diabetes (Abstract Book), Volume 58 (June 2009) Supplement 1, Page A516

11 12